Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Science ; 229(4720): 1388-90, 1985 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-2994220

RESUMO

The retrovirus frequently isolated from patients with the acquired immune deficiency syndrome (AIDS) has two novel open reading frames previously designated "A" and "B." The "A" region was found to be specifically expressed as polyadenylated RNA's of 5.5 and 5.0 kilobases in infected cells. The "B" region was expressed as 1.8- to 2.0-kilobase RNA species. Additional full-length and spliced messenger RNA's of the env region were also identified.


Assuntos
Síndrome da Imunodeficiência Adquirida/microbiologia , Deltaretrovirus/genética , Linfócitos/microbiologia , Transcrição Gênica , DNA Viral/genética , Genes Virais , Humanos , Hibridização de Ácido Nucleico , RNA Mensageiro/genética , RNA Viral/genética , Sequências Repetitivas de Ácido Nucleico
2.
Mol Cell Biol ; 9(12): 5718-21, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2555704

RESUMO

Ets1 and Ets2 are nuclear phosphoproteins which bind to DNA in vitro and share two domains of strong identity. Deletion analyses of each of these conserved regions in Ets1 demonstrated that integrity of the carboxy-terminal domain, also conserved in the more distantly related elk and erg gene products, is essential for both nuclear targeting and DNA-binding activity in vitro.


Assuntos
Proteínas de Ligação a DNA/genética , Proteínas Nucleares/genética , Proteínas Tirosina Quinases/genética , Proteínas Proto-Oncogênicas/genética , Fatores de Transcrição , Animais , Linhagem Celular , Deleção Cromossômica , Proteínas de Ligação a DNA/metabolismo , Imunofluorescência , Vetores Genéticos , Mutação , Proteínas Nucleares/metabolismo , Proteína Proto-Oncogênica c-ets-1 , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-ets , Proto-Oncogenes , Vírus 40 dos Símios/genética , Transfecção
3.
Mol Cell Biol ; 16(12): 6851-8, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8943340

RESUMO

The expression of c-ets2 is rapidly induced in a variety of myelomonocytic cell lines as they differentiate into macrophages. We find that constitutive expression of c-ets2 in the M1D+ myeloblast leukemic cell line (M1ets2) is sufficient to push these cells to a more differentiated state. The expression of several differentiation-specific genes is upregulated in M1ets2 cells, including those encoding macrophage-specific lysozyme M and tumor necrosis factor alpha, which are involved in bacteriolytic and inflammatory processes, respectively. Transcription factors c-jun and junB, previously shown to induce partial macrophage differentiation when overexpressed in myelomonocytic leukemia cell lines, are also upregulated in M1ets2 cells. The upregulation of junB is the result of a direct interaction of Ets2 with ets binding sites of the junB promoter, since transient or constitutive Ets2 expression in M1D+ cells activates junB transcription via ets binding sites. In addition, transfection of a dominant negative mutant of Ets2, devoid of its transcriptional activation domain, greatly reduces transcriptional activities of the junB promoter in M1ets2 cells. Finally, unlike their parental M1D+ counterparts, M1ets2 cells secrete the macrophage colony-stimulating factor, CSF-1, and are able to phagocytize. Taken together, these results show that when the immature myeloid M1D+ cell line constitutively expresses c-ets2, these cells acquire different functions of mature macrophages.


Assuntos
Proteínas de Ligação a DNA , Leucemia Experimental/genética , Macrófagos/patologia , Proteínas Proto-Oncogênicas/genética , Proteínas Repressoras , Transativadores/genética , Fatores de Transcrição , Animais , Diferenciação Celular/genética , Regulação Neoplásica da Expressão Gênica , Leucemia Experimental/patologia , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/patologia , Camundongos , Proteína Proto-Oncogênica c-ets-2 , Células Tumorais Cultivadas
4.
Mol Cell Biol ; 19(4): 2624-34, 1999 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10082528

RESUMO

Bcl-xL, a member of the Bcl-2 family, inhibits apoptosis, and its expression is regulated at the transcriptional level, yet nothing is known about the transcription factors specifically activating this promoter. The bcl-x promoter contains potential Ets binding sites, and we show that the transcription factor, Ets2, first identified by its sequence identity to v-ets of the E26 retrovirus, can transactivate the bcl-x promoter. Transient expression of Ets2 results in the upregulation of Bcl-xL but not of Bcl-xS, an alternatively spliced gene product which induces apoptosis. Ets2 is ubiquitously expressed at low levels in a variety of cell types and tissues but is specifically induced to abundant levels during macrophage differentiation. Since Bcl-xL is also upregulated during macrophage differentiation, we asked whether the bcl-x could be a direct downstream target gene of Ets2 in macrophages. BAC1.2F5 macrophages, which are dependent on macrophage colony-stimulating factor 1 (CSF-1) for their growth and survival, were used in these studies. We show that CSF-1 stimulation of BAC1.2F5 macrophages results in the upregulation of expression of ets2 and bcl-xL with similar kinetics of induction. In the absence of CSF-1, these macrophages undergo cell death by apoptosis, whereas constitutive expression of Ets2 rescues these cells from cell death, and bcl-xL is upregulated. These results strongly suggest a novel role of Ets2 in affecting apoptosis through its regulation of Bcl-xL transcription.


Assuntos
Apoptose/fisiologia , Proteínas de Ligação a DNA , Fator Estimulador de Colônias de Macrófagos/deficiência , Macrófagos/fisiologia , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas/genética , Proteínas Repressoras , Transativadores/genética , Fatores de Transcrição , Processamento Alternativo , Divisão Celular , Macrófagos/citologia , Fosforilação , Proteína Proto-Oncogênica c-ets-2 , Proteína do Retinoblastoma/metabolismo , Transcrição Gênica , Ativação Transcricional , Regulação para Cima , Proteína bcl-X
5.
Oncogene ; 8(2): 237-48, 1993 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8093977

RESUMO

Expression in PC12 cells of adenovirus 5 E1a proteins dramatically changes cell morphology and disrupts neuronal differentiation. We demonstrate that the nerve growth factor (NGF) receptors, p140trk and p75NGFR, as well as the epidermal growth factor receptor are undetectable in E1a-expressing PC12 cells. This correlates with a repression of mRNAs for the chromaffin- and neuronal-specific proteins, tyrosine hydroxylase and peripherin, while more ubiquitously expressed genes remain unaffected. One possible mechanism of E1a action could thus be the repression of a coordinately regulated group of chromaffin- and/or neuronal-specific genes. Furthermore, we show taht E1a conserved region 1, which binds p105Rb and p300, is necessary for this E1a-dependent effect. This indicates that cellular proteins interacting with E1a conserved region 1 may be implicated in growth arrest, expression of neuron-specific functions and orderly differentiation of PC12 cells in response to NGF.


Assuntos
Proteínas E1A de Adenovirus/farmacologia , Fatores de Crescimento Neural/farmacologia , Neurônios/efeitos dos fármacos , Proteínas E1A de Adenovirus/metabolismo , Animais , Ciclo Celular/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Regulação para Baixo , Fator de Crescimento Epidérmico/farmacologia , Receptores ErbB/análise , Fatores de Crescimento de Fibroblastos/farmacologia , Expressão Gênica/efeitos dos fármacos , Células PC12 , Receptores de Fator de Crescimento Neural/análise , Receptores de Fator de Crescimento Neural/efeitos dos fármacos , Tirosina 3-Mono-Oxigenase/genética
6.
Oncogene ; 4(6): 691-7, 1989 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2660071

RESUMO

The c-ets-1 proto-oncogene is expressed at high levels in proliferating lymphoid cells. We show here that the chicken and murine c-ets-1 proteins are predominantly localized in the cell nucleus. Over 90% of the c-ets-1 protein can be released from isolated thymocyte nuclei by treatment with low salt buffer. Release from nuclei is also observed after treatment with micrococcal nuclease, but not with RNaseA, in conditions where digestion of only a minor fraction of chromatin occurs. c-ets-1 proteins exhibit DNA binding activity, suggesting that the association to chromatin is mediated at least in part by their association to DNA. We previously showed that mitogenic stimulation of thymocytes is accompanied by the rapid calcium-dependent phosphorylation of c-ets-1 proteins. We demonstrate here that these phosphorylation events abolish the ability of c-ets-1 proteins to bind to DNA in vitro and reduce their affinity for chromatin, lending further support to the importance of these modifications in the regulation of c-ets-1 protein function.


Assuntos
Cromatina , Proteínas de Ligação a DNA/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Fatores de Transcrição , Animais , Fracionamento Celular , Núcleo Celular/metabolismo , Células Cultivadas , Galinhas , DNA/metabolismo , Proteínas de Ligação a DNA/genética , Imunofluorescência , Técnicas In Vitro , Camundongos , Nuclease do Micrococo , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Fosforilação , Proteínas Proto-Oncogênicas c-ets
7.
Oncogene ; 14(17): 2091-8, 1997 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-9160889

RESUMO

Heterodimerization among the basic-leucine zipper (bZIP) proteins or among the basic-helix-loop-helix-leucine zipper (bHLHZip) proteins confers a multitude of combinational activities to these transcription factors. To further examine the function of the bHLHZip protein, USF, we screened for cellular proteins which could directly interact with USF using the yeast two-hybrid system. A bZip protein, Fra1, was found to efficiently interact with USF. USF specifically interacts with Fra1 but not with other closely related family members, c-Fos, Fra2, FosB, or with c-Jun. Both the bHLHZip and the N-terminal regions of Fra1 are required for efficient interaction with USF. In vivo association between USF and Fra1 has been demonstrated by co-immunoprecipitation. Expression of exogenous USF led to a decrease in AP1-dependent transcription in F9 cells. Co-expression of exogenous Fra1 restored the AP1 activity in a dose-dependent manner. These data show that USF and Fra1 physically and functionally interact demonstrating that cross-talk occurs between factors of distantly related transcription families.


Assuntos
Proteínas de Ligação a DNA , Proteínas Proto-Oncogênicas c-fos/metabolismo , Fator de Transcrição AP-1/metabolismo , Fatores de Transcrição/metabolismo , Animais , Dimerização , Genes Reporter , Sequências Hélice-Alça-Hélice , Humanos , Zíper de Leucina , Camundongos , Ligação Proteica , Coelhos , Proteínas Recombinantes de Fusão/metabolismo , Saccharomyces cerevisiae/genética , Transcrição Gênica , Fatores Estimuladores Upstream , beta-Galactosidase/biossíntese
8.
Oncogene ; 5(4): 603-10, 1990 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2183162

RESUMO

We previously showed that thymocytes express high levels of c-ets-1 protein (Ets1) that can be rapidly phosphorylated following mitogenic stimulation using lectins. We demonstrate here that T cell receptor (TCR) specific stimulation with monoclonal antibodies of mature CD8+ or CD4+ T cells also results in the rapid phosphorylation of Ets1, reinforcing the hypothesis of a possible role for Ets1 in T cell activation. In addition to the major Ets1 product (mu-p63c-ets-1), we identify in mouse thymocytes and mature T cells a distinct 52 Kd Ets1 related protein (mu-p52c-ets-1). In contrast to the major Ets1 protein, mu-p52c-ets-1 is poorly phosphorylated in unstimulated cells. Furthermore, mitogenic stimulation of thymocytes and T cells failed to induce in mu-p52c-ets-1 the Ca2(+)-dependent phosphorylation events which are known to drastically affect the migration of the major Ets1 protein in SDS polyacrylamide gels. Mu-p52c-ets-1, like mu-p63c-ets-1, is a nuclear-chromatin associated protein which exhibits DNA binding activity in vitro. However, in contrast to the major Ets1 protein, the association of mu-p53c-ets-1 with chromatin and its ability to bind to DNA in vitro are unaffected by activation stimuli resulting in an increase in [Ca2+]i. Finally, we present indications suggesting that mu-p52c-ets-1 might be the murine equivalent of the translation product of an alternatively c-ets-1 spliced mRNA described in human cells by others.


Assuntos
Cálcio/metabolismo , Cromatina/metabolismo , Proteínas de Ligação a DNA/genética , Proteínas de Membrana/genética , Proteínas Proto-Oncogênicas/genética , Receptores de Antígenos de Linfócitos T/metabolismo , Linfócitos T/enzimologia , Fatores de Transcrição , Sequência de Aminoácidos , Animais , Cromatografia de Afinidade , Humanos , Camundongos , Dados de Sequência Molecular , Mapeamento de Peptídeos , Proteínas Tirosina Quinases/genética , Proteína Proto-Oncogênica c-ets-1 , Proteínas Proto-Oncogênicas/isolamento & purificação , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-ets , Homologia de Sequência do Ácido Nucleico , Linfócitos T/imunologia
9.
Cell Death Differ ; 8(3): 279-88, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11319611

RESUMO

We examined the effects of dexamethasone (DEX) on the apoptotic process in primary cultures of human and rat hepatocytes. DEX prolonged cell viability, inhibited the development of an apoptotic morphology, and stabilised the expression of procaspase-3 in both human and rat hepatocytes. In addition, the inhibition of apoptosis by DEX was strongly correlated with a decrease of caspase-3-like protease activity. Moreover, DEX treatment increased the expression of anti-apoptotic Bcl-2 and Bcl-xL proteins in human and rat hepatocytes, respectively, whereas the expression of pro-apoptotic proteins Bcl-xS or Bad was not detected or remained unchanged. The bcl-xL transcript is regulated at the transcriptional level and its expression paralleled that of Bcl-xL protein in DEX-treated rat hepatocytes. Taken together, these results indicate that this glucocorticoid exerts a protective role on cell survival and it delays apoptosis of human and rat hepatocytes by modulating caspase-3-like protease activity and bcl-2 and bcl-x gene expression.


Assuntos
Apoptose/efeitos dos fármacos , Dexametasona/farmacologia , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteína bcl-X/biossíntese , Animais , Apoptose/fisiologia , Northern Blotting , Western Blotting , Caspase 3 , Inibidores de Caspase , Caspases/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Hepatócitos/citologia , Humanos , Marcação In Situ das Extremidades Cortadas , Fígado/citologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/genética , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Regulação para Cima/efeitos dos fármacos , Proteína bcl-X/genética
10.
Cell Death Differ ; 9(9): 945-55, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12181745

RESUMO

To elucidate the biochemical pathways leading to spontaneous apoptosis in primary cultures of human and rat hepatocytes, we examined the activation of the caspase cascade, the expression of Bcl-2-related-proteins and heat shock proteins. Comparisons were made before and after dexamethasone (DEX) treatment. We show that DEX inhibited spontaneous apoptosis in a dose-dependent manner. DEX increases the expression of anti-apoptotic Bcl-2 and Bcl-x(L) proteins, decreases the expression of pro-apoptotic Bax and inhibits Bad translocation thereby preventing the release of cytochrome c, the activation of caspases, and cell death. Although, the expression of Hsp27 and Hsp70 proteins remained unchanged, the oncogenic protein c-Myc is upregulated upon DEX-treatment. These results indicate that DEX mediates its survival effect against spontaneous apoptosis by acting upstream of the mitochondrial changes. Thus, the mitochondrial apoptotic pathway plays a major role in regulating spontaneous apoptosis in these cells. Blocking this pathway therefore may assist with organ preservation for transplant, drug screening, and other purposes.


Assuntos
Apoptose/fisiologia , Dexametasona/farmacologia , Hepatócitos/metabolismo , Hepatopatias/metabolismo , Fígado/metabolismo , Mitocôndrias/metabolismo , Transdução de Sinais/fisiologia , Animais , Apoptose/efeitos dos fármacos , Proteínas de Transporte/efeitos dos fármacos , Proteínas de Transporte/metabolismo , Caspases/efeitos dos fármacos , Caspases/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Células Cultivadas , Proteína de Suscetibilidade a Apoptose Celular/efeitos dos fármacos , Proteína de Suscetibilidade a Apoptose Celular/metabolismo , Grupo dos Citocromos c/efeitos dos fármacos , Grupo dos Citocromos c/metabolismo , Relação Dose-Resposta a Droga , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Proteína Ligante Fas , Hepatócitos/efeitos dos fármacos , Humanos , Fígado/efeitos dos fármacos , Fígado/fisiopatologia , Hepatopatias/fisiopatologia , Glicoproteínas de Membrana/efeitos dos fármacos , Glicoproteínas de Membrana/metabolismo , Mitocôndrias/efeitos dos fármacos , Transporte Proteico/efeitos dos fármacos , Transporte Proteico/fisiologia , Proteínas Proto-Oncogênicas/efeitos dos fármacos , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas c-myc/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-myc/metabolismo , Ratos , Transdução de Sinais/efeitos dos fármacos , Proteína X Associada a bcl-2 , Proteína de Morte Celular Associada a bcl , Proteína bcl-X
11.
Gene ; 162(2): 297-302, 1995 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-7557447

RESUMO

We have isolated a cDNA corresponding to the hamster peroxisome proliferator-activated receptor haPPAR gamma, a member of the steroid nuclear hormone receptor superfamily of transcription factors. haPPAR gamma mRNA is highly expressed in adipose tissue, and is expressed in lung, heart, kidney, liver and spleen to a lower extent. Thus, haPPAR gamma may function in activating the transcription of target genes in a variety of tissues, including those not particularly subjected to peroxisomal beta-oxidation. haPPAR gamma binds efficiently in the presence of retinoid X receptor alpha (RXR alpha) to a peroxisome proliferator response element (PPRE) first identified in the acyl-CoA oxidase (ACO) promoter, the rate-limiting enzyme of peroxisomal beta-oxidation. The gene (ACO) encoding this enzyme has been previously shown to be under the transcriptional control of mouse PPAR (mPPAR). Although binding of haPPAR gamma/RXR alpha on the PPRE of the ACO promoter in vitro is similar to that observed for mPPAR/RXR alpha, we show that the transcriptional activities of mPPAR and haPPAR gamma are regulated differently in vivo in response to peroxisome proliferators and heterodimerization with RXR.


Assuntos
Receptores Citoplasmáticos e Nucleares/genética , Fatores de Transcrição/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Sítios de Ligação , Clonagem Molecular , Cricetinae , DNA/metabolismo , Proteínas de Ligação a DNA/metabolismo , Expressão Gênica , Camundongos , Microcorpos/fisiologia , Dados de Sequência Molecular , Oligodesoxirribonucleotídeos/química , RNA Mensageiro/genética , Sequências Reguladoras de Ácido Nucleico , Alinhamento de Sequência , Homologia de Sequência de Aminoácidos , Distribuição Tecidual , Transcrição Gênica , Xenopus laevis
12.
Biotechniques ; 29(1): 122-6, 2000 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10907087

RESUMO

We developed a program to facilitate the monitoring of biological samples (cell lines, sera, etc.) that are stored in liquid nitrogen containers. The program consists of a "virtual" container in which scientists can store their samples and a program that records the location of each sample, cell characteristics, storage dates, names of the manipulators and much more. Additional comments and a photograph can be associated with each vial, allowing for reliable tracking of samples. Vials can then be identified according to any parameter of interest to the scientist, including associated comments. Once identified, the program visually presents the location of these vials, which simplifies retrieving them from the real container. The program records the thawing of vials, along with the date and the name of the operator. Any academic laboratory requesting this standalone program will be granted a free license for its use.


Assuntos
Sistemas de Informação em Laboratório Clínico , Criopreservação , Congelamento , Nitrogênio , Manejo de Espécimes/métodos , Interface Usuário-Computador , Sangue , Linhagem Celular , Laboratórios , Software
13.
Histol Histopathol ; 16(2): 595-601, 2001 04.
Artigo em Inglês | MEDLINE | ID: mdl-11332715

RESUMO

Transcription factors play an essential role in determining the fate of a cell by affecting the expression of target genes involved in proliferation, in differentiation and in programmed cell death. Under certain conditions, some of these factors are capable of deregulating expression of genes involved in the cell cycle and/or in programmed cell death resulting in uncontrolled proliferation of the cell. The focus of this review is on the transcriptional regulation of the bcl-x gene encoding the anti-apoptotic Bcl-xL protein. Since 1999, several papers have implicated members of the Ets, Rel/NFkappaB, STAT and AP-1 families as transcription factors regulating bcl-x expression. A specific emphasis of these different transcription factor families on bcl-x regulation in hematopoietic cells is discussed.


Assuntos
Apoptose/genética , Regulação da Expressão Gênica , Proteínas Proto-Oncogênicas c-bcl-2/genética , Fatores de Transcrição/fisiologia , Transcrição Gênica , Animais , Humanos , Camundongos , NF-kappa B/fisiologia , Proteínas Proto-Oncogênicas/fisiologia , Proteínas Proto-Oncogênicas c-ets , Fator de Transcrição AP-1/fisiologia , Ativação Transcricional , Proteína bcl-X
14.
BMC Genet ; 2: 4, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11252156

RESUMO

BACKGROUND: A growing number of laboratories are using the mouse as a model system in developmental biology as well as in molecular biology. Surprisingly, most of these laboratories do not have reliable computerized systems to track these animals, and the few commercial solutions available are expensive. We thus developed MICE (Mouse Information and Classification Entity), a program aimed at facilitating the monitoring of animals in animal facilities. RESULTS: This program consists of a virtual facility in which scientists can perform all the tasks done in the real world (i.e., receiving animals, breeding them, preparing cage labels, etc.). Recording of each animal (birth date, cage number, ID number, tail analysis number, parents, genetic status, genetic background, etc.) enables reliable tracking. According to any parameter of interest, animals can then be identified, grouped, sorted, moved, and so forth. Crossings are automatically processed by the program. For example, new genetic backgrounds, generation number, and anticipated due dates are determined. The program also reminds the user when new births are expected and entering newborn animals only requires a few clicks. The genealogy of each animal can be determined in two different ways, one being the visualization of a genealogical tree from which information of ancestors can be retrieved. CONCLUSION: This standalone program, that will be distributed free of charge to academic laboratories requesting a license, represents a new and valuable tool for all animal facility users, and permits simple and reliable tracking and retrieving of animals.


Assuntos
Camundongos , Software , Animais , Cruzamento , Abrigo para Animais , Camundongos/classificação , Camundongos/genética , Linhagem
15.
Bull Cancer ; 88(4): 363-8, 2001 Apr.
Artigo em Francês | MEDLINE | ID: mdl-11371370

RESUMO

The considerable progress of molecular biology within the past twenty years has permitted a more and more detailed characterization of the molecular mechanisms regulating cell proliferation. The corollary to these discoveries has been the identification of different deregulations yielding to cell transformation and cancer. The goal of this review is to present new therapeutic tools that stemmed from the now well understood logic underlying cell transformation. These tools, based on the intimate understanding of signalization pathways, aim at restoring the molecular controls which had been abrogated during the process of cell transformation. We present a survey of these new proposed therapeutic strategies. These new approaches will probably allow the clinician, in the near future, to combine traditional therapies with more targeted ones, and thus to limit side effects often associated with classical cancer therapies, while improving the overall effect of the treatment.


Assuntos
Anticarcinógenos/uso terapêutico , Divisão Celular/genética , Transformação Celular Neoplásica/genética , Neoplasias/genética , Animais , Divisão Celular/efeitos dos fármacos , Transformação Celular Neoplásica/efeitos dos fármacos , Humanos , Neoplasias/prevenção & controle , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Transcrição Gênica/efeitos dos fármacos , Transcrição Gênica/genética
16.
Arthritis Rheum ; 52(9): 2708-18, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16142752

RESUMO

OBJECTIVE: To investigate why bisphosphonates are less effective at preventing focal bone loss in rheumatoid arthritis (RA) patients than in those with generalized osteoporosis, and the mechanisms involved. METHODS: The response of osteoclasts to alendronate (ALN) in tumor necrosis factor-transgenic (TNF-Tg) mice that develop erosive arthritis and in wild-type littermates was studied. TNF-Tg and wild-type mice were given ALN, and the osteoclast numbers in the inflamed joints and in the long bones were compared. The expression levels of Bcl-xL in the osteoclasts of TNF-Tg and wild-type mice were examined by immunostaining. The effect of overexpression of Bcl-xL and Ets-2 proteins on ALN-induced osteoclast apoptosis was determined using an in vitro osteoclast survival assay and retrovirus transfer approach. RESULTS: ALN reduced osteoclast numbers in the metaphyses by 97%, but by only 46% in the adjacent inflamed joints. Bcl-xL expression was markedly higher in osteoclasts in the joints than in those in the metaphyses of TNF-Tg mice. Bcl-xL or Ets-2 overexpression protected osteoclasts from ALN-induced apoptosis, and TNF stimulated Bcl-xL and Ets-2 expression in osteoclasts. Overexpression of Ets-2 increased Bcl-xL messenger RNA in osteoclasts, while a dominant-negative form of the Ets-2 blocked the protective effect of Bcl-xL or TNF on ALN-induced apoptosis. CONCLUSION: The reduced efficacy of bisphosphonates to stop bone erosion in the inflamed joints of RA patients may result from local high levels of TNF up-regulating Ets-2 expression in osteoclasts, which in turn stimulates Bcl-xL expression in them and reduces their susceptibility to bisphosphonate-induced apoptosis.


Assuntos
Alendronato/uso terapêutico , Apoptose , Artrite Experimental , Osteoclastos/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Fatores de Transcrição/metabolismo , Fator de Necrose Tumoral alfa/metabolismo , Alendronato/farmacologia , Animais , Artrite Experimental/tratamento farmacológico , Artrite Experimental/metabolismo , Artrite Experimental/patologia , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/metabolismo , Células da Medula Óssea/patologia , Sobrevivência Celular , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Técnicas Imunoenzimáticas , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Transgênicos , Osteoclastos/efeitos dos fármacos , Osteoclastos/patologia , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-ets , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Transcrição/genética , Fator de Necrose Tumoral alfa/genética , Regulação para Cima , Proteína bcl-X
17.
Eur J Biochem ; 241(1): 249-53, 1996 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-8898913

RESUMO

Upstream stimulatory factor (USF) is a transcription factor of the basic region/helix-loop-helix/leucine repeat family. It shares the same DNA-binding sequence as the myc oncogene. Based on the three-dimensional structures, its DNA-binding domain is structurally related to that of Max, the partner of Myc. In addition, USF can form heterodimers with a related factor, Fos-interacting protein/upstream stimulatory factor 2 (FIP/USF2), which has been shown to directly interact with Fos. In view of the provocative relationship of USF with other factors involved in cell proliferation, we investigated whether USF could also play a role in cellular growth control. In this study, we report that USF is not an oncogene, but interferes with Ras-driven transformation. This inhibitory effect is independent of USF transactivating domains, but requires its DNA-binding activity. However, the minimal USF DNA-binding domain does not display this inhibitory effect, and even slightly enhances Ras transformation. On the basis of these data, we propose that USF may play an important role in the control of cell growth and proliferation, through both binding to promoter sequences and specific protein/protein interactions.


Assuntos
Genes ras/genética , Sequências Hélice-Alça-Hélice , Fatores de Transcrição/farmacologia , Transformação Genética/efeitos dos fármacos , Células 3T3 , Sequência de Aminoácidos , Animais , Sítios de Ligação , Western Blotting , Divisão Celular/efeitos dos fármacos , Divisão Celular/genética , Extratos Celulares/farmacologia , Clonagem Molecular , Proteínas de Ligação a DNA/farmacologia , Regulação da Expressão Gênica/genética , Camundongos , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida/genética , Ligação Proteica , Fatores Estimuladores Upstream
18.
J Virol ; 62(2): 376-86, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2826802

RESUMO

Leukemogenic mink cell focus-forming (MCF) viruses of AKR mice are believed to originate in thymic tissue via recombination between ecotropic, xenotropiclike, and endogenous MCF-related murine leukemia virus (MuLV) sequences. We have previously used a synthetic 16-base-pair MCF env-specific oligomer probe to identify subgenomic MCF-related mRNAs present in the thymus tissues of AKR mice prior to the appearance of full-length (8.4-kilobase [kb]) recombinant MCF viral RNAs (A. S. Khan, F. Laigret, and C. P. Rodi, J. Virol. 61:876-882, 1987). These potential MCF env precursors consisted of 7.2-, 3.0-, and 1.8-kb RNA species. In this study, we have determined the structure of the MCF-related mRNAs on the basis of Northern (RNA) blot hybridization analyses by using 10 different MuLV subgenomic DNA probes, determined the nucleotide sequence of a cloned cDNA segment representing the 3' portion of the 7.2-kb mRNA, and studied the expression of ecotropic and xenotropic MuLV sequences by using env-specific DNA probes. The results indicated that ecotropic, xenotropic, and MCF-related transcripts were constitutively and concurrently expressed exclusively in thymus tissue of 2-month-old AKR mice prior to detection of MCF viral RNAs. We have molecularly characterized these thymic MuLV RNAs, which may participate in formation of recombinant MCF viruses; a novel recombinant ecotropic viral RNA was identified as a putative intermediate in the stepwise generation of leukemogenic MCF MuLVs. We have also described the unique structure of the 6.0-kb MCF-related RNAs which were expressed specifically in liver and kidney tissues of AKR mice; these RNAs contained an upstream non-MuLV transcriptional regulatory element.


Assuntos
Vírus da Leucemia Murina/genética , Vírus Indutores de Focos em Células do Vison/genética , Precursores de RNA/genética , RNA Mensageiro/genética , RNA Viral/genética , Timo/microbiologia , Sequência de Aminoácidos , Animais , Autorradiografia , Sequência de Bases , Clonagem Molecular , DNA Viral/genética , Genes Virais , Cinética , Camundongos , Camundongos Endogâmicos AKR , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Sequências Repetitivas de Ácido Nucleico , Homologia de Sequência do Ácido Nucleico , Transcrição Gênica
19.
J Cell Sci ; 108 ( Pt 2): 675-83, 1995 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7539437

RESUMO

A murine protein, termed CDEBP, was previously shown to bind the double-stranded DNA motif GTCACATG, identical to the yeast centromeric element CDEI. The cDNA sequence showed three domains with extensive similarities to the amyloid beta precursor protein (APP). The protein is homologous over its entire length to the human protein designated APPH. In situ immunofluorescence assays using antibodies raised against distinct parts of CDEBP detected discrete sites of accumulation inside the interphase nucleus, and the bulk of the protein was not associated with mitotic chromosomes. One of the complexes with double-stranded CDEI oligonucleotides detected by gel shift assay was not present when the protein had been selectively removed from nuclear extracts by immunoprecipitation. We reported previously that microinjection into one-cell mouse embryos of DNA fragments including the CDEI sequence results in an early arrest of development with abnormal nuclei containing variable amounts of DNA. The same characteristic figures were observed when embryos were treated with antisense oligonucleotides complementary to parts of the CDEBP coding region. Complexes between the CDEBP protein and CDEI sites in the mouse genome thus appear to play a critical role in the replication/segregation of the embryonic genome.


Assuntos
Proteínas de Ligação a DNA/fisiologia , Desenvolvimento Embrionário e Fetal/fisiologia , Células 3T3 , Sequência de Aminoácidos , Precursor de Proteína beta-Amiloide/genética , Animais , Sequência de Bases , Núcleo Celular/metabolismo , DNA Complementar , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Desenvolvimento Embrionário , Desenvolvimento Embrionário e Fetal/genética , Feminino , Interfase , Camundongos , Camundongos Endogâmicos , Dados de Sequência Molecular , Oligonucleotídeos Antissenso/farmacologia , Gravidez , RNA/genética , Homologia de Sequência de Aminoácidos
20.
EMBO J ; 7(4): 977-83, 1988 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-3136014

RESUMO

Human, murine and chicken c-ets-1 proteins migrate in SDS-polyacrylamide gels as multiple species. We show here that most if not all of this heterogeneity is due to phosphorylation events occurring predominantly on serine and to a lesser extent on threonine residues. These phosphorylations can be specifically and rapidly stimulated by treatment with the calcium ionophore A23187 or abolished by lowering the extracellular calcium concentration to less than 0.1 microM. The products encoded by c-ets-2 are also phosphorylated in a Ca2+-dependent manner, indicating that these modifications have been conserved in the products encoded by different members of the same gene family. In thymocytes, where the expression of c-ets-1 is elevated as compared with other cell types, c-ets-1 protein phosphorylation occurs after stimulation with mitogenic doses of concanavalin A, is short lived and is strictly dependent upon extracellular Ca2+ sources. This suggests that the c-ets-1 gene product may play a role in the Ca2+-mediated early events linked to T-cell activation.


Assuntos
Cálcio/farmacologia , Ativação Linfocitária , Proteínas Proto-Oncogênicas/genética , Linfócitos T/imunologia , Fatores de Transcrição , Animais , Calcimicina/farmacologia , Galinhas , Concanavalina A/farmacologia , Ácido Egtázico/farmacologia , Humanos , Camundongos , Fosforilação , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-ets , Proto-Oncogenes , Linfócitos T/efeitos dos fármacos , Linfócitos T/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA